{"generated":"2026-10-19T13:52:54.457Z","checked":{"drugs":93,"trials":135},"mismatches":[{"check":"trial-status-vs-registry","id":"nct03054870","name":"CYC-009: Technegas versus xenon-133 ventilation imaging","route":"/trials/nct03054870/","recorded":"historic","registry":"TERMINATED","url":"https://clinicaltrials.gov/study/NCT03054870","severity":"high"},{"check":"enrolled-vs-registry","id":"nct06906471","name":"A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS","route":"/trials/nct06906471/","recorded":"enrolled 10","registry":"enrolment 15 (actual)","url":"https://clinicaltrials.gov/study/NCT06906471","severity":"medium"},{"check":"enrolled-vs-registry","id":"radiant-3-4","name":"RADIANT-3 and RADIANT-4","route":"/trials/radiant-3-4/","recorded":"enrolled 712","registry":"enrolment 410 (actual)","url":"https://clinicaltrials.gov/study/NCT00510068","severity":"medium"},{"check":"nct-title-mismatch","id":"decision-sorafenib","name":"DECISION","route":"/trials/decision-sorafenib/","recorded":"NCT00984282: \"DECISION\"","registry":"Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer","url":"https://clinicaltrials.gov/study/NCT00984282","severity":"medium"},{"check":"nct-title-mismatch","id":"ion-trial","name":"IoN","route":"/trials/ion-trial/","recorded":"NCT01398085: \"IoN\"","registry":"IoN: IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients","url":"https://clinicaltrials.gov/study/NCT01398085","severity":"medium"},{"check":"nct-title-mismatch","id":"rathl","name":"RATHL","route":"/trials/rathl/","recorded":"NCT00678327: \"RATHL\"","registry":"Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Sta","url":"https://clinicaltrials.gov/study/NCT00678327","severity":"medium"},{"check":"enrolled-vs-registry","id":"psmaddition","name":"PSMAddition","route":"/trials/psmaddition/","recorded":"enrolled 1144","registry":"enrolment 1140 (actual)","url":"https://clinicaltrials.gov/study/NCT04720157","severity":"low"},{"check":"enrolled-vs-registry","id":"rathl","name":"RATHL","route":"/trials/rathl/","recorded":"enrolled 1214","registry":"enrolment 1202 (actual)","url":"https://clinicaltrials.gov/study/NCT00678327","severity":"low"},{"check":"enrolled-vs-registry","id":"nct06590857","name":"Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.","route":"/trials/nct06590857/","recorded":"enrolled 16","registry":"enrolment 64 (estimated)","url":"https://clinicaltrials.gov/study/NCT06590857","severity":"low"},{"check":"us-approval-no-openfda-label","id":"cu-64-dotatate","name":"Copper-64 dotatate","route":"/drugs/cu-64-dotatate/","recorded":"US approval 2020","registry":"no openFDA label for \"Copper-64 dotatate\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"f-18-fet","name":"Floretyrosine F-18 (FET)","route":"/drugs/f-18-fet/","recorded":"US approval 2026","registry":"no openFDA label for \"Floretyrosine\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"f-18-florquinitau","name":"Florquinitau F-18","route":"/drugs/f-18-florquinitau/","recorded":"US approval 2026","registry":"no openFDA label for \"Florquinitau\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"f-18-flurpiridaz","name":"Flurpiridaz F-18","route":"/drugs/f-18-flurpiridaz/","recorded":"US approval 2024","registry":"no openFDA label for \"Flurpiridaz\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"ga68-dotatate","name":"Gallium-68 DOTATATE (and Cu-64 DOTATATE)","route":"/drugs/ga68-dotatate/","recorded":"US approval 2016","registry":"no openFDA label for \"Gallium-68 DOTATATE\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"ga-68-dotatoc","name":"Gallium-68 edotreotide (DOTATOC)","route":"/drugs/ga-68-dotatoc/","recorded":"US approval 2019","registry":"no openFDA label for \"Gallium-68 edotreotide\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"in-111-pentetreotide","name":"Indium-111 pentetreotide","route":"/drugs/in-111-pentetreotide/","recorded":"US approval 1994","registry":"no openFDA label for \"Indium-111 pentetreotide\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"iobenguane-i-131","name":"Iobenguane I-131 (therapeutic)","route":"/drugs/iobenguane-i-131/","recorded":"US approval 2018","registry":"no openFDA label for \"Iobenguane I-131\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"i-131-tositumomab","name":"Iodine-131 tositumomab","route":"/drugs/i-131-tositumomab/","recorded":"US approval 2003","registry":"no openFDA label for \"Iodine-131 tositumomab\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"radioactive-iodine","name":"Radioactive iodine (I-131)","route":"/drugs/radioactive-iodine/","recorded":"US approval 1951","registry":"no openFDA label for \"Radioactive iodine\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"radium-223","name":"Radium-223 dichloride","route":"/drugs/radium-223/","recorded":"US approval 2013","registry":"no openFDA label for \"Radium-223 dichloride\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"rb-82-chloride","name":"Rubidium Rb-82 chloride","route":"/drugs/rb-82-chloride/","recorded":"US approval 1989","registry":"no openFDA label for \"Rubidium Rb-82 chloride\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"samarium-153-lexidronam","name":"Samarium-153 lexidronam","route":"/drugs/samarium-153-lexidronam/","recorded":"US approval 1997","registry":"no openFDA label for \"Samarium-153 lexidronam\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"sr-89-chloride","name":"Strontium-89 chloride","route":"/drugs/sr-89-chloride/","recorded":"US approval 1993","registry":"no openFDA label for \"Strontium-89 chloride\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"technegas","name":"Technegas (technetium Tc-99m labelled carbon inhalation aerosol)","route":"/drugs/technegas/","recorded":"US approval 2023","registry":"no openFDA label for \"Technegas\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"tc-99m-maa","name":"Technetium Tc-99m albumin aggregated (MAA)","route":"/drugs/tc-99m-maa/","recorded":"US approval 1987","registry":"no openFDA label for \"Technetium Tc-99m albumin aggregated\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"tc-99m-mdp","name":"Technetium Tc-99m medronate (MDP)","route":"/drugs/tc-99m-mdp/","recorded":"US approval 1972","registry":"no openFDA label for \"Technetium Tc-99m medronate\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"tc-99m-pyrophosphate","name":"Technetium Tc-99m pyrophosphate","route":"/drugs/tc-99m-pyrophosphate/","recorded":"US approval 1976","registry":"no openFDA label for \"Technetium Tc-99m pyrophosphate\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"tc-99m-sestamibi","name":"Technetium Tc-99m sestamibi","route":"/drugs/tc-99m-sestamibi/","recorded":"US approval 1990","registry":"no openFDA label for \"Technetium Tc-99m sestamibi\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"tc-99m-tetrofosmin","name":"Technetium Tc-99m tetrofosmin","route":"/drugs/tc-99m-tetrofosmin/","recorded":"US approval 1996","registry":"no openFDA label for \"Technetium Tc-99m tetrofosmin\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"tc-99m-hmpao-brain","name":"Technetium-99m exametazime (brain perfusion)","route":"/drugs/tc-99m-hmpao-brain/","recorded":"US approval 1994","registry":"no openFDA label for \"Technetium-99m exametazime\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"tilmanocept-tc99m","name":"Technetium-99m tilmanocept","route":"/drugs/tilmanocept-tc99m/","recorded":"US approval 2013","registry":"no openFDA label for \"Technetium-99m tilmanocept\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"tl-201-chloride","name":"Thallous chloride Tl-201","route":"/drugs/tl-201-chloride/","recorded":"US approval 1977","registry":"no openFDA label for \"Thallous chloride Tl-201\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"y-90-glass-microspheres","name":"Yttrium-90 glass microspheres","route":"/drugs/y-90-glass-microspheres/","recorded":"US approval 2021","registry":"no openFDA label for \"Yttrium-90 glass microspheres\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"},{"check":"us-approval-no-openfda-label","id":"y-90-resin-microspheres","name":"Yttrium-90 resin microspheres","route":"/drugs/y-90-resin-microspheres/","recorded":"US approval 2002","registry":"no openFDA label for \"Yttrium-90 resin microspheres\"","url":"https://open.fda.gov/apis/drug/label/","severity":"low"}],"errors":[]}